RxDoctor Payments Data

Yury Rotshteyn

Foot & Ankle Surgery · Brooklyn, NYNPI 1033346721

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (40.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Kerecis Limited at 45.7% of the total. 2025 is the largest year on record at $13,937, 4.7 times the $2,957 reported in 2019. Among foot & ankle surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$43,367in general payments, 2019–2025

Across 208 payments — averaging $208.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kerecis Limited$20K
  • Treace Medical Concepts, Inc.$5K
  • Stryker$4K
  • Paragon 28, Inc.$3K
  • KCI USA, Inc.$2K
  • Medline Industries LP$2K
  • plus $8K from 29 others

What the payments were for

  • Consulting fees$5,92314%
  • Speaking & faculty fees$17,32640%
  • Travel & lodging$7,72918%
  • Food & beverage$10,60324%
  • Education$1,7854%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,367 in reported general payments places this provider in the 95th percentile of 652 foot & ankle surgery providers in New York.

See all foot & ankle surgery providers in New York

Medicare billing

Part B allowed, 2024
$311,428
Medicare patients
1,224
Services billed
5,170

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium87$13,916
Clotrimazole236$5,301
Triamcinolone Acetonide11$4,698
Ammonium Lactate311$3,816
Doxepin Hcl28$2,913
Diclofenac Sodium ErDiclofenac Sodium25$1,922
Fluocinonide15$1,135
Ciclopirox14$896
SsdSilver Sulfadiazine18$603
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip28$545
Lidocaine23$543
Ketoconazole16$516
Silver Sulfadiazine13$313
Mupirocin43$236
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav28$147

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →